Aigen Investment Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-8,783
Closed -$932K 598
2025
Q4
$932K Sell
8,783
-5,407
-38% -$627K 0.22% 136
2025
Q3
$1.8M Buy
14,190
+769
+6% +$91.5K 0.28% 84
2025
Q2
$1.65M Buy
+13,421
New +$1.53M 0.23% 133
2021
Q4
Sell
-13,165
Closed -$786K 1067
2021
Q3
$786K Buy
+13,165
New +$828K 0.15% 177
2020
Q3
Sell
-8,335
Closed -$411K 917
2020
Q2
$411K Buy
+8,335
New +$450K 0.05% 522
2020
Q1
Sell
-16,972
Closed -$935K 1333
2019
Q4
$935K Buy
+16,972
New +$921K 0.15% 191

Other funds holding EHC

Aigen Investment Management's EHC Position: Q1 2026 in Review

Aigen Investment Management sold out of Encompass Health (EHC) in Q1 2026, closing a stake of 8,783 shares — an estimated $932K sold.

Aigen Investment Management first reported a position in EHC in Q4 2019 and held it in 6 quarters. The position peaked at $1.8M in Q3 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Aigen Investment Management reported no remaining Encompass Health position as of Q1 2026 after selling out during the quarter.
  • Aigen Investment Management sold 8,783 Encompass Health shares in Q1 2026, an estimated $932K.
  • Aigen Investment Management first reported a position in Encompass Health in Q4 2019 and held it in 6 quarters.
  • Aigen Investment Management's Encompass Health position peaked at $1.8M in Q3 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Aigen Investment Management's 13F filing for Q1 2026, filed 15 May 2026.